XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.4
NET INCOME PER CLASS A COMMON SHARE (Tables)
 9 Months Ended
Dec. 05, 2020
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The components of basic and diluted net income per Class A common share were as follows (in millions, except per share data):
12 weeks ended40 weeks ended
December 5,
2020		November 30,
2019		December 5,
2020		November 30,
2019
Basic net income per Class A common share
Net income$123.7 $54.8 $994.4 $398.6 
Accrued dividends on Convertible Preferred Stock(27.3)— (58.1)— 
Earnings allocated to Convertible Preferred Stock— — (25.4)— 
Net income allocated to Class A common stockholders - Basic$96.4 $54.8 $910.9 $398.6 
Weighted average Class A common shares outstanding - Basic (1)468.7 579.4 511.0 579.3 
Basic net income per Class A common share$0.21 $0.09 $1.78 $0.69 
Diluted net income per Class A common share
Net income allocated to Class A common stockholders - Basic$96.4 $54.8 $910.9 $398.6 
Accrued dividends on Convertible Preferred Stock— — 58.1 — 
Earnings allocated to Convertible Preferred Stock— — 25.4 — 
Net income allocated to Class A common stockholders - Diluted$96.4 $54.8 $994.4 $398.6 
Weighted average Class A common shares outstanding - Basic (1)468.7 579.4 511.0 579.3 
Dilutive effect of:
   Restricted stock units and awards3.4 1.5 4.0 0.5 
   Convertible preferred stock (2)— — 65.3 — 
Weighted average Class A common shares outstanding - Diluted (3)472.1 580.9 580.3 579.8 
Diluted net income per Class A common share$0.20 $0.09 $1.71 $0.69 
(1) There were no common shares remaining to be issued for the 12 and 40 weeks ended December 5, 2020, compared to 0.1 million common shares remaining to be issued for the 12 and 40 weeks ended November 30, 2019, respectively.
(2) Reflects the number of shares of Convertible Preferred Stock issued, if converted into Common Stock for the period outstanding.
(3) There were 101.6 million potential common shares outstanding related to convertible preferred stock that were antidilutive for the 12 weeks ended December 5, 2020 and no potential common shares outstanding that were antidilutive for the 40 weeks ended December 5, 2020. There were no potential common shares outstanding that were antidilutive for the 12 and 40 weeks ended November 30, 2019.